The Impact of Bisphosphonates on Bone Loss in Patients Undergoing Surgery and Postoperative Chemotherapy for Gynecologic Malignancies.

Trial Profile

The Impact of Bisphosphonates on Bone Loss in Patients Undergoing Surgery and Postoperative Chemotherapy for Gynecologic Malignancies.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2011

At a glance

  • Drugs Alendronic acid/colecalciferol (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2011 Planned end date changed from 1 Feb 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top